131 related articles for article (PubMed ID: 8409409)
1. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses.
Molina IJ; Sancho J; Terhorst C; Rosen FS; Remold-O'Donnell E
J Immunol; 1993 Oct; 151(8):4383-90. PubMed ID: 8409409
[TBL] [Abstract][Full Text] [Related]
2. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells.
Schwinzer R; Franklin RA; Domenico J; Renz H; Gelfand EW
J Immunol; 1992 Mar; 148(5):1322-8. PubMed ID: 1371524
[TBL] [Abstract][Full Text] [Related]
4. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
[TBL] [Abstract][Full Text] [Related]
6. Evidence for IL-2 independent proliferation in human T cells.
Laing TJ; Weiss A
J Immunol; 1988 Feb; 140(4):1056-62. PubMed ID: 2830333
[TBL] [Abstract][Full Text] [Related]
7. Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway.
Romano MF; Turco MC; Stanziola A; Giarrusso PC; Petrella A; Tassone P; van Lier R; Venuta S; Formisano S
Cell Immunol; 1993 May; 148(2):455-63. PubMed ID: 8098674
[TBL] [Abstract][Full Text] [Related]
8. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
9. Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3.
Geppert TD; Lipsky PE
J Immunol; 1987 Mar; 138(6):1660-6. PubMed ID: 3102594
[TBL] [Abstract][Full Text] [Related]
10. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome.
Simon HU; Mills GB; Hashimoto S; Siminovitch KA
J Clin Invest; 1992 Oct; 90(4):1396-405. PubMed ID: 1401074
[TBL] [Abstract][Full Text] [Related]
11. Activation of resting T cells against the CA 72-4 tumor antigen with an anti-CD3/CA 72-4 bispecific antibody in combination with a costimulatory anti-CD28 antibody.
Hombach A; Mathas S; Jensen M; Tillmann T; Menges M; Diehl V; Kruis W; Pohl C
Anticancer Res; 1997; 17(3C):2025-32. PubMed ID: 9216660
[TBL] [Abstract][Full Text] [Related]
12. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA
Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD3-stimulated Ca2+ signal in individual human peripheral T cells. Activation correlates with a sustained increase in intracellular Ca2+1.
Wacholtz MC; Lipsky PE
J Immunol; 1993 Jun; 150(12):5338-49. PubMed ID: 8515062
[TBL] [Abstract][Full Text] [Related]
14. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
[TBL] [Abstract][Full Text] [Related]
15. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.
Siefken R; Kurrle R; Schwinzer R
Cell Immunol; 1997 Feb; 176(1):59-65. PubMed ID: 9070318
[TBL] [Abstract][Full Text] [Related]
16. CD2 regulates T cell-dependent induction of monocyte IL-1 beta mRNA during anti-CD3 mitogenesis.
McAllister PT; Ellis TM
Cell Immunol; 1996 May; 170(1):120-6. PubMed ID: 8660807
[TBL] [Abstract][Full Text] [Related]
17. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
[TBL] [Abstract][Full Text] [Related]
18. A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms.
Siminovitch KA; Greer WL; Novogrodsky A; Axelsson B; Somani AK; Peacocke M
J Investig Med; 1995 Apr; 43(2):159-69. PubMed ID: 7735919
[TBL] [Abstract][Full Text] [Related]
19. Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28.
Molinero LL; Fuertes MB; Rabinovich GA; Fainboim L; Zwirner NW
J Leukoc Biol; 2002 May; 71(5):791-7. PubMed ID: 11994503
[TBL] [Abstract][Full Text] [Related]
20. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
